Nick Smith | Senior Director, Corporate Development & IR |
Norbert Riedel | President & Chief Executive Officer |
Ashish Khanna | Chief Financial Officer & Chief Business Officer |
Andy Kidd | Chief Operating Officer |
Kathryn King | Senior Vice President, Clinical Development |
Rolando Gutierrez | Senior Vice President, Medical and Pharmacovigilance |
Chris Raymond | Piper Sandler |
Marc Goodman | SVB Leerink |
Ritu Baral | Cowen |
Charles Duncan | Cantor Fitzgerald |
Gary Nachman | BMO Capital Markets |
Joon Lee | Truist Securities |
Kenneth Shield | Wedbush Securities |
Myles Minter | William Blair |
Ram Selvaraju | H.C. Wainwright |
Jessica Fye | JPMorgan |
Good afternoon and welcome to the Aptinyx Third Quarter 2020 Financial Results Conference Call. At this time, all participants are on listen-only mode.
Following the formal remarks, we will open up the call for your questions. Please be advised the call is being recorded at the Company's request. At this time, I would like to turn the call over to Nick Smith, Senior Director of Corporate Development and Investor Relations at Aptinyx.